Under construction – not a live service
Sign in
Taking people in FinlandNo phase

Tests a laser eye procedure added to cataract surgery in normal tension glaucoma

Tests whether adding endoscopic laser treatment to cataract surgery lowers eye pressure in glaucoma.

Plain-language title generated from the registry record
Registry title: Endoscopic Cyclophotocoagulation in Normal Tension Glaucoma

Key facts

Where
Helsinki, FinlandSee the site

Could this be for you?

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 55 and 100 years old?

Source: NCT04651530, who can take part

Where in Finland

  • Helsinki University HospitalHelsinki, FinlandTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Helsinki University Central Hospital
Trial code
NCT04651530
Record updated
22 December 2020
Original description
The purpose of this study is to assess whether endoscopic cyclophotocoagulation added to cataract surgery lowers intraocular pressure more than cataract surgery alone in patients with normal tension glaucoma.Read full original descriptionShow less

Endoscopic Cyclophotocoagulation in Normal Tension Glaucoma

The purpose of this study is to assess whether endoscopic cyclophotocoagulation added to cataract surgery lowers intraocular pressure more than cataract surgery alone in patients with normal tension glaucoma.

Inclusion: Signed Informed Consent; Normal Tension Glaucoma with typical nerve fiber layer defects in red-free photographs and/or optical coherence tomography (OCT) and possible equivalent visual field defects, IOP never more than 21 mmHg, and open anterior chamber angle; Glaucoma stable with current medication assessed by a glaucoma specialist; Clinically significant cataract.

Exclusion: Secondary Glaucoma e.g. due to previous injury or uveitis; Previous transscleral or endoscopic cyclophotocoagulation; Previous other glaucoma surgery; Previous retinal detachment; Previous intraocular surgery like vitrectomy and other retinal surgery; Previous corneal transplant or previous refractive surgery; Exfoliation syndrome; Pigment dispersion syndrome; Zonular weakness due to Marfan syndrome or other; Dementia; Wet age-related macular degeneration; Cataract due to eye injury or congenital cataract; Diabetic retonopathy; Fuchs' dystrophy and other abnormalities compromising corneal clarity like scars; The patient does not want to participate in the study; The glaucoma progresses on current IOP; The patient does not speak Finnish, Swedish or English; Only eye with vision worse than 20/200 or loss of central visual field.

ClinicalTrials.gov NCT04651530